Key facts
- Mindera Health’s last known valuation is $80.3M (Dec 2022).
- It has raised $63.4M.
- Notable investors include MedTech Innovator, Grant Park Ventures, Bank Saint Petersburg, MIT Alumni Angels of Northern California, Mountain Group Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Mindera Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Mindera Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mindera Health
Developer of molecular testing technology designed to be used for skin diseases and conditions. The company specializes in creating and commercializing non-invasive, high-precision genomic tools for skin diseases by using a dermal biomarker patch and generates clinically validated data to reduce healthcare system costs and improve patient outcomes, enabling healthcare institutions and patients to access pain-free, minimally invasive, and targeted extraction of mRNA from the skin, without requiring a skin biopsy.
- Sector
- Healthcare
- HQ
- Vista, CA, United States
- Founded
- 2013
- Employees
- 24
- Website
- minderahealth.com/
- Ownership
- Privately Held (backing)
Mindera Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mindera Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mindera Health in its N-PORT filings yet. We sweep new filings monthly.